Laura M. Kreckler

475 total citations
10 papers, 428 citations indexed

About

Laura M. Kreckler is a scholar working on Physiology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Laura M. Kreckler has authored 10 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 2 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Laura M. Kreckler's work include Adenosine and Purinergic Signaling (5 papers), Cardiac Ischemia and Reperfusion (2 papers) and Neuropeptides and Animal Physiology (2 papers). Laura M. Kreckler is often cited by papers focused on Adenosine and Purinergic Signaling (5 papers), Cardiac Ischemia and Reperfusion (2 papers) and Neuropeptides and Animal Physiology (2 papers). Laura M. Kreckler collaborates with scholars based in United States and Switzerland. Laura M. Kreckler's co-authors include John A. Auchampach, Tina C. Wan, Zhi‐Dong Ge, Elizabeth Gizewski, Garrett J. Gross, Jason N. Peart, Marlene A. Jacobson, Dharini van der Hoeven, Jason E. Maas and Jayashree Narayanan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Cancer Research.

In The Last Decade

Laura M. Kreckler

10 papers receiving 418 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Laura M. Kreckler 300 147 76 69 65 10 428
Marzena Grdeń 244 0.8× 91 0.6× 62 0.8× 36 0.5× 22 0.3× 23 399
Jocelyne Condo 164 0.5× 127 0.9× 34 0.4× 27 0.4× 15 0.2× 19 537
Mark D. Okusa 57 0.2× 191 1.3× 77 1.0× 71 1.0× 56 0.9× 12 407
Leonóra Himer 413 1.4× 127 0.9× 180 2.4× 114 1.7× 13 0.2× 8 557
Christian Karcher 153 0.5× 143 1.0× 63 0.8× 21 0.3× 14 0.2× 10 357
Magdalena A. Zabielska-Kaczorowska 111 0.4× 160 1.1× 35 0.5× 9 0.1× 36 0.6× 27 409
Albert G. Driver 193 0.6× 81 0.6× 84 1.1× 34 0.5× 5 0.1× 8 427
Wiwin Is Effendi 62 0.2× 97 0.7× 34 0.4× 19 0.3× 14 0.2× 16 283
Tullio Di Perri 56 0.2× 45 0.3× 11 0.1× 20 0.3× 38 0.6× 19 329
Annette Pexa 80 0.3× 77 0.5× 10 0.1× 4 0.1× 42 0.6× 16 389

Countries citing papers authored by Laura M. Kreckler

Since Specialization
Citations

This map shows the geographic impact of Laura M. Kreckler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura M. Kreckler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura M. Kreckler more than expected).

Fields of papers citing papers by Laura M. Kreckler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura M. Kreckler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura M. Kreckler. The network helps show where Laura M. Kreckler may publish in the future.

Co-authorship network of co-authors of Laura M. Kreckler

This figure shows the co-authorship network connecting the top 25 collaborators of Laura M. Kreckler. A scholar is included among the top collaborators of Laura M. Kreckler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura M. Kreckler. Laura M. Kreckler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Faivre, Emily J., Marybeth A. Pysz, Laura M. Kreckler, et al.. (2024). Abstract 3148: ABBV-706 is a novel SEZ6-targeted topoisomerase 1 inhibitor ADC for SCLC and other neuroendocrine cancers. Cancer Research. 84(6_Supplement). 3148–3148. 1 indexed citations
2.
Reilly, Regina M., Mark G. Anderson, Lora A. Tucker, et al.. (2023). Abstract 6311: ABBV-400: An ADC delivering a novel topoisomerase 1 inhibitor to c-Met-positive solid tumors. Cancer Research. 83(7_Supplement). 6311–6311. 7 indexed citations
3.
Kreckler, Laura M., Mark A. Osinski, Scott M. Williams, & R.L. Whiting. (2022). Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2/D3 Selective Receptor Antagonist for the Management of Gastroparesis. SHILAP Revista de lepidopterología. 5 indexed citations
4.
Kreckler, Laura M., Mark A. Osinski, Scott A. Williams, & R.L. Whiting. (2020). Su1739 SAFETY PHARMACOLOGY EVALUATIONS OF TAK-906, A NOVEL DOPAMINE D2/D3 SELECTIVE RECEPTOR ANTAGONIST FOR THE MANAGEMENT OF GASTROPARESIS. Gastroenterology. 158(6). S–627. 5 indexed citations
5.
Hoeven, Dharini van der, Tina C. Wan, Elizabeth Gizewski, et al.. (2011). A Role for the Low-Affinity A2B Adenosine Receptor in Regulating Superoxide Generation by Murine Neutrophils. Journal of Pharmacology and Experimental Therapeutics. 338(3). 1004–1012. 44 indexed citations
6.
Kreckler, Laura M., Elizabeth Gizewski, Tina C. Wan, & John A. Auchampach. (2009). Adenosine Suppresses Lipopolysaccharide-Induced Tumor Necrosis Factor-α Production by Murine Macrophages through a Protein Kinase A- and Exchange Protein Activated by cAMP-Independent Signaling Pathway. Journal of Pharmacology and Experimental Therapeutics. 331(3). 1051–1061. 38 indexed citations
7.
Auchampach, John A., Laura M. Kreckler, Tina C. Wan, et al.. (2009). Characterization of the A2B Adenosine Receptor from Mouse, Rabbit, and Dog. Journal of Pharmacology and Experimental Therapeutics. 329(1). 2–13. 32 indexed citations
8.
Ge, Zhi‐Dong, Jason N. Peart, Laura M. Kreckler, et al.. (2006). Cl-IB-MECA [2-Chloro-N6-(3-iodobenzyl)adenosine-5′-N-methylcarboxamide] Reduces Ischemia/Reperfusion Injury in Mice by Activating the A Adenosine Receptor. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1200–1210. 81 indexed citations
9.
Kreckler, Laura M., Tina C. Wan, Zhi‐Dong Ge, & John A. Auchampach. (2006). Adenosine Inhibits Tumor Necrosis Factor-α Release from Mouse Peritoneal Macrophages via A2A and A2B but Not the A3 Adenosine Receptor. Journal of Pharmacology and Experimental Therapeutics. 317(1). 172–180. 179 indexed citations
10.
Auchampach, John A., Xiaowei Jin, Jeannine Moore, et al.. (2004). Comparison of Three Different A1 Adenosine Receptor Antagonists on Infarct Size and Multiple Cycle Ischemic Preconditioning in Anesthetized Dogs. Journal of Pharmacology and Experimental Therapeutics. 308(3). 846–856. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marzena Grdeń Breakdown of academic impact, for papers by Jocelyne Condo Breakdown of academic impact, for papers by Mark D. Okusa Breakdown of academic impact, for papers by Leonóra Himer Breakdown of academic impact, for papers by Christian Karcher Breakdown of academic impact, for papers by Magdalena A. Zabielska-Kaczorowska Breakdown of academic impact, for papers by Albert G. Driver Breakdown of academic impact, for papers by Wiwin Is Effendi Breakdown of academic impact, for papers by Tullio Di Perri Breakdown of academic impact, for papers by Annette Pexa
Rankless by CCL
2026